This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Edwards, JenaValve argue merger is 'best hope to save thousands of lives'

( November 6, 2025, 23:31 GMT | Official Statement) -- MLex Summary: Medical device creators Edwards Lifesciences and JenaValve Technology urged US District Judge Rudolph Contreras to deny the Federal Trade Commission's motion for a preliminary injunction against their proposed merger. The firms described their deal as "the best hope to save thousands of lives" by accelerating the refinement, commercialization and distribution of new heart valve devices that are currently being vetted by the Food and Drug Administration.See attached document. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login